文献速递心境障碍

经颅时间干涉刺激治疗双相障碍抑郁发作的可行性研究

Transcranial temporal interference stimulation for treating bipolar disorder with depressive episodes: a feasibility Study.
PubMed 文献 · Mol Psychiatry · 2025-10-02

该单臂开放标签试验招募36例双相障碍抑郁发作患者,25例完成5天共10次针对左侧伏隔核的经颅时间干涉刺激。治疗后HAMD-17、MADRS、HAMA及QIDS评分均显著下降,部分患者达改善或应答标准,认知功能改善且不良事件轻微。

要点

  • tTIS靶向左侧伏隔核可显著降低双相抑郁患者抑郁及焦虑量表评分。
  • 44.0%患者达改善标准,28.0%达应答标准,认知功能见改善。
  • 不良事件以短暂头皮不适为主,安全性初步良好。

核心结论

  • 经颅时间干涉刺激对双相障碍抑郁发作患者的抑郁症状及认知损害具有初步疗效和安全性证据。

研究设计与样本

  • 单臂开放标签试验,招募36例双相障碍抑郁发作患者,25例完成5天共10次tTIS干预。

主要发现

  • HAMD-17平均分从23.36降至16.16(p < 0.0001),MADRS从39.12降至31.28(p < 0.01)。
  • HAMA平均分从19.68降至15.44(p < 0.05),QIDS从13.52降至9.68(p < 0.001)。
  • 认知评估显示记忆和执行功能改善,奖赏相关脑活动变化与症状减轻正相关。
  • 不良事件轻微,主要为短暂头皮不适。

关键数值与推荐

  • 每次tTIS session持续20分钟,最大电流强度2 mA,包络刺激频率40 Hz,靶点左侧伏隔核。
  • 共10次session,5天内完成。

临床怎么用

  • tTIS可作为双相抑郁伴认知损害的潜在非侵入性干预选项,需在试验条件下进一步验证。

局限性

  • 单臂开放标签设计,样本量有限(完成25例),缺乏对照,结论需随机对照试验证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bipolar depression (BD-D) is a significant clinical challenge associated with high disease burden. Transcranial temporal interference stimulation (tTIS), a novel and noninvasive approach for targeting deep brain structures, was investigated for its efficacy and safety in BD-D patients in this trial. Thirty-six patients were recruited for a single-arm, open-label trial, and 25 completed the 5-day intervention consisting of 10 tTIS sessions targeting the left nucleus accumbens. Each session lasted 20 min, with a maximum current intensity of 2 mA and an envelope stimulation frequency of 40 Hz. Significant symptom reductions were observed following treatment, with mean HAMD-17 scores decreasing from 23.36 to 16.16 (p < 0.0001), MADRS scores from 39.12 to 31.28 (p < 0.01), HAMA scores from 19.68 to 15.44 (p < 0.05), and QIDS scores from 13.52to 9.68 (p < 0.001). Eleven participants (44.0%) met improvement criteria and seven (28.0%) achieved response. Cognitive assessments indicated improvements in memory and executive function, and changes in reward-related brain activity correlated positively with symptom reduction. Adverse events were mild, mainly transient scalp discomfort. These findings provide preliminary evidence supporting the efficacy and safety of tTIS for alleviating depressive symptoms and cognitive impairments in BD-D.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhou H, Wang M, Qi S, et al. Transcranial temporal interference stimulation for treating bipolar disorder with depressive episodes: a feasibility Study. Mol Psychiatry. 2025. PMID: 41039090. doi:10.1038/s41380-025-03292-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。